We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Reagent Strips Test Analyzed for CSF in Neurological Disorders

By LabMedica International staff writers
Posted on 05 Jun 2019
Cerebrospinal fluid (CSF) examination is often performed in emergency to obtain diagnostic information of various life threatening conditions such as meningitis, subarachnoid hemorrhage, demyelinating diseases or carcinomas.

Initial evaluation of CSF includes protein, glucose and microscopic analysis including total and differential cell count, which requires well-equipped laboratory and trained staff. More...
Sometimes, these facilities are not available in the small health care facilities with limited resources.

Medical laboratory scientists at the Institute of Human Behavior and Allied Sciences (Delhi, India) conducted a study of 360 samples of CSF that were received in emergency laboratory of a tertiary care hospital in a period of six months. This study included samples of patients with age ranged from 11 to 78 years, median being 25 years. Almost equal numbers of male and female cases were found with 174 male cases and 186 female cases. Most of the cases in the study were of meningitis [tuberculous: 240 cases (66 %), bacterial: 80 cases (22%), aseptic: 30 cases (8%)]. There were six cases (1%) of Guillain–Barré syndrome (GBS), three cases (0.8%) of sub-acute sclerosing panencephalitis (SSPE) and one case (0.2%) of CNS tumor.

All CSF samples were subjected to two types of tests-the definitive test and the index test. CSF microscopy for leucocyte and erythrocyte as well as biochemistry tests for protein and glucose on automated biochemistry analyzer were considered as definitive test. Other reference standard tests like CSF protein and glucose were performed on the biochemistry analyzer by pyrogallol red method and glucose oxidase-peroxidase (GOD-POD) method.

The Combur‑10 urinary reagent strip was used as index test to detect CSF leucocytes by leukocyte esterase estimation, glucose-by-glucose oxidase-peroxidase method, protein levels by pyrogallol red method and erythrocytes by peroxidase method. The technicians, who performed the index test, were blinded to the results of definitive tests. Undiluted CSF was mixed with the micropipette and 2–3 drops of CSF was then added to patches of leucocytes, proteins, sugar and erythrocytes and reaction was noted after 60 to 120 seconds. Then, reaction colors of the test area were compared with the color chart on the label.

The scientists reported that the combur-10 strip test showed a sensitivity of 99% and a specificity of 54 % for proteins. With respect to glucose, the strip was highly sensitive (98%) as well as highly specific (92%). It showed a high sensitivity of 100% and 96% specificity for leukocytes greater than or equal to 10 cells/mm3. For CSF erythrocytes sensitivity and specificity was 100%. The authors decided that the sensitivity and specificity of this method was found to be reasonably high for all parameters when compared with standardized methods performed on advanced equipment.

They concluded that Combur‑10 urinary reagent strips are very efficient in rapid evaluation of CSF in various neurological disorders, especially in emergency settings where turn-around time is crucial. Since this method does not require any expertise, it could be helpful if implemented properly in small laboratories or in rural areas where high-end equipment and trained technical staff are lacking. The study was published on May 21, 2019, in the journal Practical Laboratory Medicine.

Related Links:
Institute of Human Behavior and Allied Sciences


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Specimen Radiography System
TrueView 200 Pro
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.